enilconazole has been researched along with Disbacteriosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Z; Jin, C; Jin, Y; Pan, Z; Tu, W; Wang, Y; Wu, S; Xia, J | 1 |
| Fu, Z; Jin, C; Jin, Y; Zeng, Z | 1 |
2 other study(ies) available for enilconazole and Disbacteriosis
| Article | Year |
|---|---|
Insights Into a Possible Influence on Gut Microbiota and Intestinal Barrier Function During Chronic Exposure of Mice to Imazalil.
Topics: Animals; Biological Transport; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Dysbiosis; Feces; Fungicides, Industrial; Gastrointestinal Microbiome; Hydrogen Bonding; Imidazoles; Intestines; Male; Mice, Inbred C57BL; Molecular Docking Simulation; Transcriptome | 2018 |
Oral imazalil exposure induces gut microbiota dysbiosis and colonic inflammation in mice.
Topics: Actinobacteria; Animals; Bacteroidetes; Colon; Dysbiosis; Feces; Fungicides, Industrial; Gastrointestinal Microbiome; Humans; Imidazoles; Liver; Male; Mice; Proteobacteria; RNA, Ribosomal, 16S; Tumor Necrosis Factor-alpha | 2016 |